Suppr超能文献

应激相关的心身障碍:采用无线电不平衡治疗进行心理评估的随机单盲安慰剂对照自然研究

Stress-related psycho-physiological disorders: randomized single blind placebo controlled naturalistic study of psychometric evaluation using a radio electric asymmetric treatment.

机构信息

Department of Neuro-Psycho-Physio Pathology and Neuro Psycho Physical Optimization, Rinaldi Fontani Institute, Viale Belfiore 43, Florence 50144, Italy.

出版信息

Health Qual Life Outcomes. 2011 Jul 19;9:54. doi: 10.1186/1477-7525-9-54.

Abstract

BACKGROUND

The aim of this study is to investigate the effects of a radio electric asymmetric treatment on psycho-physiological disorders (PPD). PPD are often stress related and are under the unconscious control of the patient and cannot be traced back to any serious physical disease. The brain stimulation treatment protocol used is called Neuro Psycho Physical Optimization (NPPO) with a Radio Electric Asymmetric Conveyer (REAC) device.

METHODS

Psychological stress and PPD were measured for a group of 888 subjects using the Psychological Stress Measure (PSM) test, a self-administered questionnaire. Data were collected immediately before and after the 4-weeks of REAC treatment cycle.

RESULTS

This study showed a significant reduction in scores measuring subjective perceptions of stress for subjects treated with a cycle of NPPO REAC treatment. At the end-point the number of subjects reporting symptoms of stress-related PPD on the PSM test was significantly reduced, whereas in the placebo group the difference was not significant.

CONCLUSION

A cycle of NPPO treatment with REAC was shown to reduce subjective perceptions of stress measured by the PSM test and in particular on PPD.

TRIAL REGISTRATION

This trial has been registered in the Australian New Zealand Clinical Trials Registry (ANZCTR) with the number: ACTRN12607000463471.

摘要

背景

本研究旨在探讨无线电电不对称治疗对心理生理障碍(PPD)的影响。PPD 通常与压力有关,处于患者的无意识控制之下,无法追溯到任何严重的身体疾病。使用的脑刺激治疗方案称为神经心理物理优化(NPPO)与无线电电不对称输送器(REAC)设备。

方法

使用心理应激量表(PSM)测试对 888 名受试者的心理应激和 PPD 进行测量,这是一种自我管理的问卷。数据在接受 4 周 REAC 治疗周期前后收集。

结果

本研究表明,接受 NPPO-REAC 治疗周期的受试者的主观应激评分显著降低。在终点,报告 PSM 测试中应激相关 PPD 症状的受试者数量明显减少,而在安慰剂组中差异不显著。

结论

REAC 的 NPPO 治疗周期被证明可以减少 PSM 测试测量的主观应激感知,特别是在 PPD 方面。

试验注册

本试验已在澳大利亚新西兰临床试验注册中心(ANZCTR)注册,编号为:ACTRN12607000463471。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/108a/3150240/464b74acecbf/1477-7525-9-54-1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验